Made Scientific and Pluristyx Launch Integrated iPSC Development & Manufacturing Partnership to Advance Next-Generation iPSC-derived Cell Therapies

Summary

Made Scientific and Pluristyx have launched a strategic partnership integrating Pluristyx's clinical-grade iPSC platform with Made Scientific's CDMO services to provide developers a single-source path from cell line development to commercial supply for iPSC-derived cell therapies.